DOP026: Sustained remission with vedolizumab in patients with Moderately to Severely active Ulcerative Colitis: A GEMINI 1 post hoc analysis of Week 14 remittersECCO'17 Barcelona 2017
1
DOP027: Long-term efficacy and safety of ustekinumab in refractory Crohn’s Disease patients: A multicenter retrospective experienceECCO'17 Barcelona 2017
1
DOP028: Antibodies towards vedolizumab appear from week 2 onwards and disappear upon treatmentECCO'17 Barcelona 2017
1
DOP029: Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: Post-hoc analysis of the taxit trialECCO'17 Barcelona 2017
1
DOP030: Anti-TNF re-induction is as effective, simpler and cheaper compared with dose interval shortening following secondary loss of response in Crohn’s Disease: A dual centre ‘real world’ studyECCO'17 Barcelona 2017
1
DOP031: Subtherapeutic serum infliximab trough levels and complete mucosal healing are associated with sustained clinical remission after infliximab discontinuation in paediatric Crohn’s Disease patientsECCO'17 Barcelona 2017
1
DOP032: Hydrocortisone premedication withdrawal in patients on stable infliximab maintenance: Clinical and pharmacokinetic outcomesECCO'17 Barcelona 2017
1
DOP033: Severely active Ulcerative Colitis is associated with high baseline infliximab clearance, reduced serum half-life and worse endoscopic outcomesECCO'17 Barcelona 2017
1
DOP034: Serum adalimumab concentration 3 months after surgery is correlated with endoscopic recurrence in Crohn’s Disease patients treated with adalimumab for prevention of postoperative recurrenceECCO'17 Barcelona 2017
1
DOP035: High gammaglobulin and low albumin serum levels independently predict secondary loss of response to anti-TNFα therapy in IBDECCO'17 Barcelona 2017
1
DOP036: The therapeutic efficacy of anti-TNF requires Fc-gamma receptors and can be improved by antibody hypo-fucosylationECCO'17 Barcelona 2017
1
DOP037: A model for prediction of early surgery and complications in paediatric Crohn’s Disease; Results of the prospective GROWTH CD studyECCO'17 Barcelona 2017
1
DOP039: Postoperative infectious complications in Crohn’s Disease: results from PRACTICROHN studyECCO'17 Barcelona 2017
1
DOP040: Postoperative surgical recurrence in Crohn’s Disease decreases significantly in the biologic eraECCO'17 Barcelona 2017
1
DOP041: Prepouch ileitis after ileal pouch anal anastomosis for Ulcerative Colitis: Patterns of presentation and risk factors for failure of treatmentECCO'17 Barcelona 2017
1
DOP042: Omentectomy is not necessary during laparoscopic total coloproctectomy and ileal Pouch-anal anastomosis for inflammatory bowel disease. A comparative study in 247 consecutive patients from 4 expert centresECCO'17 Barcelona 2017
1
DOP043: High risk of pouch dysplasia in IBD-PSC patients following total proctocolectomyECCO'17 Barcelona 2017
1
DOP044: Relationship between microbiota and development of early postoperative Crohn’s Disease recurrenceECCO'17 Barcelona 2017
1